Aimed Trial Srl

Revolutionizing Clinical Trials with AI and Computational Innovation At AIMED Trial, we believe that clinical research can be more efficient, faster and safer through artificial intelligence and computational technologies. That's why we develop innovative solutions that transform the way clinical trials are designed and conducted, accelerating timelines, reducing costs, and risks, and improving outcomes. Our solutions: Synthetic Control Groups (SCAs)- We create synthetic control groups for non-randomised studies, particularly useful in certain types of oncological, neurological, respiratory and cardiovascular diseases. GenAI-Driven Real-World Evidence (RWE)- From RWD to RWE, overcoming the limitations of traditional observational studies with artificial intelligence. Synthetic Clinical Data Generation - We produce robust statistical datasets, ensuring privacy and regulatory compliance. Clinical Trial Simulations - We reduce costs and risks by accurately predicting immune responses to experimental drugs. We address the most complex challenges in clinical research, such as RWD exploitation, data scarcity, privacy protection and the need for high quality and rapidly analysed data. Our goal is the implementation of the clinical research of the future, with applications driven by generative artificial intelligence.